Lysosomal-associated transmembrane protein 5 (LAPTM5) [31], involved in lysosome biogenesis and function, has been identified as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy [32] and was upregulated in insulin resistance and obesity [33, 34]. Here, LAPTM5 is linked to Insulin resistance.